ValuEngine downgraded shares of Lakeland Industries (NASDAQ:LAKE) from a strong-buy rating to a buy rating in a research note published on Thursday, ValuEngine reports.

Other analysts have also recently issued research reports about the company. Roth Capital set a $15.00 target price on Lakeland Industries and gave the company a buy rating in a research report on Tuesday. Zacks Investment Research raised Lakeland Industries from a hold rating to a buy rating and set a $13.00 target price on the stock in a research report on Thursday.

NASDAQ:LAKE traded up $0.38 during midday trading on Thursday, hitting $11.88. The stock had a trading volume of 4,355 shares, compared to its average volume of 15,968. Lakeland Industries has a one year low of $9.70 and a one year high of $14.44. The company has a market capitalization of $90.69 million, a price-to-earnings ratio of 28.98 and a beta of 0.61. The stock has a 50-day moving average of $10.72 and a 200 day moving average of $11.45. The company has a quick ratio of 2.09, a current ratio of 5.49 and a debt-to-equity ratio of 0.04.

Lakeland Industries (NASDAQ:LAKE) last announced its quarterly earnings data on Monday, September 9th. The medical instruments supplier reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.16. Lakeland Industries had a positive return on equity of 1.67% and a negative net margin of 0.49%. The company had revenue of $27.47 million for the quarter, compared to analysts’ expectations of $25.62 million. On average, sell-side analysts anticipate that Lakeland Industries will post 0.45 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the company. BlackRock Inc. lifted its holdings in shares of Lakeland Industries by 6.4% during the 2nd quarter. BlackRock Inc. now owns 48,078 shares of the medical instruments supplier’s stock valued at $539,000 after purchasing an additional 2,890 shares during the last quarter. Granite Investment Partners LLC lifted its holdings in shares of Lakeland Industries by 88.6% during the 1st quarter. Granite Investment Partners LLC now owns 50,854 shares of the medical instruments supplier’s stock valued at $597,000 after purchasing an additional 23,894 shares during the last quarter. Equitable Trust Co. lifted its holdings in shares of Lakeland Industries by 6.2% during the 2nd quarter. Equitable Trust Co. now owns 56,449 shares of the medical instruments supplier’s stock valued at $632,000 after purchasing an additional 3,300 shares during the last quarter. Kennedy Capital Management Inc. purchased a new stake in shares of Lakeland Industries during the 1st quarter valued at $1,723,000. Finally, Vanguard Group Inc. lifted its holdings in shares of Lakeland Industries by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 316,934 shares of the medical instruments supplier’s stock valued at $3,550,000 after purchasing an additional 10,278 shares during the last quarter. Hedge funds and other institutional investors own 60.33% of the company’s stock.

About Lakeland Industries

Lakeland Industries, Inc manufactures and sells a range of safety garments and accessories for the industrial and public protective clothing market in the United States and internationally. It offers limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks; high-end chemical protective suits to provide protection from highly concentrated, and hazardous chemical and biological toxins; and firefighting and heat protective apparel to protect against fire, burns, and excessive heat.

Featured Article: What is the Dividend Aristocrat Index?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.